The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans

Chest

Volumn 116, Issue 4, 1999, Pages 880-886

  Hooper, W Craig ^a   Lally, Cathy ^a   Austin, Harland ^a   Benson, Jane ^a   Dilley, Anne ^a   Wenger, Nanette Kass ^a   Whitsett, Carolyn ^a   Rawlins, Peggy ^a   Evatt, Bruce L ^a  

^a NONE

Author keywords

African Americans; Endothelial cell nitric oxide synthase; Glycoprotein IIb IIIa receptor; Myocardial infarction; Venous thrombosis

Indexed keywords

GLYCOPROTEIN IIIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY RISK; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0032717816     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.4.880     Document Type: Article

References (36)

1. 1 Warren JB, Pons F, Brady AJB. Nitric oxide biology: implications for cardiovascular therapeutics. Cardiovasc Res 1994; 28:25-30
2. 2 Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48:489-509
3. 3 Clarkson P, Celermajer DS, Powe AJ, et al. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary artery disease. Circulation 1997; 96:3378-3383
4. 4 Hasdai D, Gibbons RJ, Holmes DR, et al. Coronary artery dysfunction in hnmans is associated myocardial perfusion defects. Circulation 1997; 96:3390-3395
5. 5 Higman DJ, Strachan AMJ, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 1996; 16:546-552
6. 6 Higman DJ, Greenhalgh RM, Powell JT. Smoking impairs endothelinm-dependent relaxation In saphenous vein. Br J Surg 1993; 80:1242-1245
7. 7 Ku DD, Caulfield B, Kirklin JK. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation 1993; 83:402-411
8. 8 Broeders MAW, Tangelder G-J, Slaaf DW, et al. Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles. Arterioscler Thromb Vasc Biol 1998; 18: 139-145
9. 9 Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 1997; 48:489-509
10. 10 Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70:36-41
11. 11 Tanner FC, Boulanger CM, Luscher TF. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Semin Thromb Hemost 1993; 19:167-175
12. 12 Lamas S, Marsden PA, Li GK, et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89:6348-6352
13. A polymorphism of glycoprotein IIb/IIIa and the fibrinogen B-beta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96:1424-1431
14. 14 Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell 1991; 65:359-362
15. 15 Wu KK, Phillips M, Souza DD, et al. Platelet activation and arterial disease. Lancet 1994; 334:991-995
16. 16 Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87:1234-1240
17. 17 Eikenboom JCJ. Reitsma PH, Briet E. The inheritance and molecular genetics of von Willebrand's disease. Hemophilia 1995; 1:77-90
18. 18 Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326:242-250
19. 19 Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992; 326:310-318
20. 20 Wang XL, Sim AS, Badenhop RF, et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2:41-45
21. 21 Ichihara S, Yamada Y, Fujimura T, et al. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 81:83-86
22. 22 Weiss EJ. Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334:1090-1094
23. PIA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low-risk patients. Thromb Hemost 1998; 80:214-217
24. 24 Martin D, Austin H. An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio. Epidemiology 1991; 2:359-362
25. 25 Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley & Sons; 1989
26. 26 Boger RH, Boger-Bode SM, Thiele W, et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95: 2068-2074
27. 27 Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995; 38:105-128
28. 28 Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997; 17:3147-3153
29. 29 Lefkovits J. Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332:1553-1559
30. 30 Hooper WC, Dilley A, Ribeiro MJ, et al. A racial difference in the prevalence of the Arg506→Gln imitation. Thromb Res 1996; 81:577-581
31. 31 Austin H, Hooper WC, Dilley A, et al. The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans. Thromb Res 1997; 86:409-413
32. 32 Dilley A, Hooper WC, Austin H, et al. The relationship of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998; 147:30-38
33. 33 Dilley A, Austin H, Hooper WC, et al. The prevalence of the prothrombin 20210 G to A variant in African-Americans: infants, venous thrombosis patients, myocardial infarction patients and controls. In press
34. A1/A2 polymorphism of platelet glycoprotein IIIa and risk of myocardial infarction, stroke and venous thrombosis. Lancet 1997; 349: 385-358
35. A1/A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM study. Thromb Hemost 1997; 77:1179-1181
36. 36 Corral J, Conejero-Gonzalez. R, Rivera J, et al. HFA-1 genotype in arterial thrombosis-role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 1997; 8:284-290